Use of hydroxychloroquine, remdesivir, and dexamethasone among adults hospitalized with COVID-19 in the United States: Results from the National COVID Cohort Collaborative (N3C)

Mehta, H. B.; An, H. J.; Andersen, K. M.; Mansour, O.; Madhira, V.; Rashidi, E. S.; Bates, B.; Setoguchi, S.; Joseph, C.; Kocis, P.; Moffitt, R.; Bennett, T. D.; Chute, C.; Garibaldi, B. T.; Alexander, G. C.

Mehta, H. B.; An, H. J.; Andersen, K. M.; Mansour, O.; Madhira, V.; Rashidi, E. S.; Bates, B.; Setoguchi, S.; Joseph, C.; Kocis, P.; Moffitt, R.; Bennett, T. D.; Chute, C.; Garibaldi, B. T.; Alexander, G. C..

Pharmacoepidemiology and Drug Safety ; 30:27-27, 2021.

Article in English | Web of Science | ID: covidwho-1381720

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Pharmacoepidemiology and Drug Safety Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML